CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 335 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04873700
NCT04873700N/ACompleted

Real-world Data of Moderate to Severe Inflammatory Bowel Disease (UC and CD) in Mexico: a Multicenter, Non-interventional Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Patient Reported Outcomes

Takeda·observational·Posted May 5, 2021·Updated Nov 7, 2024

In Brief

An observational study for Inflammatory Bowel Diseases and 2 related conditions. Completed, enrolled 335 participants across 12 sites.

Detailed Summary

The main aim of this study is to check the disease activity in people with moderate to severe ulcerative colitis and Crohn's disease. Participants will complete questionnaires about their disease and quality of life on Day 1 clinic visit. They will do this during a standard scheduled appointment with their doctor. Some of this study will also involve collecting information about participants from their medical records.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesMexico
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 5, 2021
Enrollment StartAug 30, 2021
Primary CompletionMay 17, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.2 years ago